Compare FTAI Aviation Ltd (FTAI) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FTAI Aviation Ltd vs Mesoblast Limited — how do they compare? FTAI Aviation Ltd trades at $231.5 (market cap $23.17B), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: FTAI Aviation Ltd is far larger — about 10.5× Mesoblast Limited's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| FTAI | MESO | |
|---|---|---|
Market Cap | $23.17B | $2.21B |
Sector | Industrials | Technology |
52-Week High | $310.04 | $20.96 |
52-Week Low | $140.40 | $12.88 |
Enterprise Value | $26.29B | $2.21B |
Dividend Yield | 0.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
